ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 30, 2010

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration

February 23, 1990

Panel To Hear Centers’ Problems Again; Alabama, Mayo Impress Site visitors

March 18, 1977

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986